xconomy lung cancer cells.jpeg

"Cancer immunotherapy combinations continue to chalk up wins against lung cancer. For the first time, an immunotherapy-chemotherapy combination has succeeded in a late-stage study of patients with small cell lung cancer (SCLC), a particularly aggressive form of the disease often linked to smoking."

--Xconomy, June 25, 2018

Interesting article about combinations therapies successfully fighting small cell lung cancer for the first time.   Therapies combining immunotherapies and chemotherapies are already being used to treat non-small cell lung cancers.  Read the full post HERE